Sanofi receives USFDA approval for Calibri
Sanofi India has received USFDA approval for its drug Calbivi which is tested to treat a rare blood-clotting disorder in adults in combination with standard-of-care […]
USFDA
Alembic receives USFDA approval for Acetazolamide
Alembic Pharmaceuticals has received final USFDA approval for Acetazolamide extended-release capsules, used for the treatment of various kinds of glaucoma. The drug is therapeutically equivalent […]
Glenmark Pharma receives USFDA approval for Sevelamer Hydrochloride
Glenmark Pharma has received final USFDA approval for Sevelamer Hydrochloride tablets to market the same in US markets. The product is prescribe for controlling serum […]
Wockhardt receives USFDA approval for generic prostrate cancer tablet abiraterone acetate
Wockhardt has received final USFDA approval for its generic prostrate cancer tablet abiraterone acetate. The drug in strength of 250mg is a generic version of […]
Strides Pharma Science receives USFDA approval for Triamcinolone Acetonide
Strides Pharma Science (Strides) through Strides Pharma Global, Singapore has received USFDA approval for its drug Triamcinolone Acetonide to market the same in US markets. […]
Glenmark receives USFDA approval for Derma Smoothe Topical oil
Glenmark Pharmaceuticals has received final USFDA approval for generic version of Derma-Smoothe Topical Oil, used in the treatment of scalp psoriasis. The topical oil is […]
Cipla receives USFDA approval for Medroxyprogesterone injectable
Cipla has received final USFDA approval for Medroxyprogesterone injectable for prevention of pregnancy in the markets of America. The injection Medroxyprogesterone injectable 150mg/million is a […]
DRL receives USFDA approval for Tosymra – migraine spray
Dr Reddy’s Laboratories Ltd has received USFDA approval for ‘Tosymra’ spray which is used to treat acute migraine with or without aura in adults. The […]
Wockhardt receives USFDA approval for Imatinib Mesylate
Wockhardt has received final USFDA approval for 100 mg and 400 mg tablets of Imatinib Mesylate to market the same in US markets. The drug […]
Cadila receives USFDA approval for Acetazolamide ER
Zydus Cadila has received the final USFDA approval to market Acetazolamide ER Capsules. Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used […]